What's new in general surgery: Surgical oncology

Journal of the American College of Surgeons

Volumn 198, Issue 6, 2004, Pages 966-988

  Lafrenière, Rene ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

DCIS; ductal carcinoma in situ; endoscopic ultrasonography; EUS; HCC; hepatocellular carcinoma; PE; preoperative embolization; radiofrequency ablation; reverse transcriptase polymerase chain reaction; RFA; RT PCR

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; CISPLATIN; MITOMYCIN C; TEMOZOLOMIDE; THALIDOMIDE;

ADENOCARCINOMA; BILE DUCT CARCINOMA; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CHEMOEMBOLIZATION; COLON CARCINOMA; COLORECTAL CANCER; DIAGNOSTIC IMAGING; ESOPHAGUS CANCER; GALLBLADDER CANCER; GALLBLADDER CARCINOMA; GENERAL SURGERY; HEPATOBILIARY DISEASE; HUMAN; HYPERTROPHY; INTRAOPERATIVE PERIOD; LIVER CANCER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; LIVER TUMOR; LYMPH NODE METASTASIS; MELANOMA; PANCREAS CANCER; PANCREAS TUMOR; PERITONEAL DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM CANCER; RECTUM CARCINOMA; REVIEW; SARCOMA; SENTINEL LYMPH NODE BIOPSY; STOMACH CANCER; WOUND INFECTION;

EID: 2942550650     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2004.03.010     Document Type: Article

References (127)

1. Etzioni D.J., Lui J.H., Maggard M.A., et al. Workload projections for surgical oncology Will we need more surgeons? Ann Surg Oncol. 10:2003;1112-1117
2. Stuart K. Chemoembolization in the management of liver tumors. Oncologist. 8:2003;425-437
3. Kurumiya Y., Nagino M., Nozawa K., et al. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer. Surgery. 133:2003;512-520
4. Yoshimura Y., Kubo S., Hirohashi K., et al. Plastic iodophor drape during liver surgery operative use of the iodophor-impregnated adhesive drape to prevent wound infection during high risk surgery. World J Surg. 27:2003;685-688
5. Nagano Y., Togo S., Tanaka K., et al. Risk factors and management of bile leakage after hepatic resection. World J Surg. 27:2003;695-698
6. D'Angelica M., Fong Y., Weber S., et al. The role of staging laparoscopy in hepatobiliary malignancy Prospective analysis of 4012 cases. Ann Surg Oncol. 10:2003;183-189
7. Okada Y., Nagino M., Kamiya J., et al. Diagnosis and treatment of inferior vena caval invasion by hepatic cancer. World J Surg. 27:2003;689-694
8. 99mTc-GSA SPECT scintigraphy. Surgery. 133:2003;495-506
9. Sarmiento J., Heywood G., Rubin J., et al. Surgical treatment of neuroendocrine metastases to the liver A plea for resection to increase survival. J Am Coll Surg. 197:2003;29-37
10. Behari A., Sikora S., Wagholikar G., et al. Longterm survival after extended resections in patients with gallbladder cancer. J Am Coll Surg. 196:2003;82-88
11. Jaeck D. The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol. 10:2003;1007-1011
12. Sakamoto Y., Ohyama S., Yamamoto J., et al. Surgical resection of liver metastases of gastric cancer An analysis of a 17-year experience with 22 patients. Surgery. 133:2003;507-511
13. Puhalla H., Gruenberger T., Pokomy H., et al. Resection of hilar cholangiocarcimomas Pivotal prognostic factors and impact of tumor sclerosis. World J Surg. 27:2003;680-684
14. Cha C., Fong Y., Jarnagin W.R., et al. Predictors and patterns of recurrence after resection of hepatocellular carcinomas. J Am Coll Surg. 197:2003;753-758
15. De Carlis L., Giacomoni A., Pirotta V., et al. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg. 196:2003;887-897
16. Harrison L.E., Koneru B., Baramipour P., et al. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg. 197:2003;759-764
17. Arch-Ferrer J.E., Smith J.K., Bynon S., et al. Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma. Am Surg. 70:2003;1067-1071
18. Bleicher R.J., Allegra D.P., Nora D.T., et al. Radiofrequency ablation in 447 complex unresectable liver tumors Lessons learned. Ann Surg Oncol. 10:2003;52-58
19. Izzo F. Other thermal ablation techniques Microwave and interstitial laser ablation of liver tumors. Ann Surg Oncol. 10:2003;491-497
20. Rivadeneira D.E., Pochapin M., Grobmyer S.R., et al. Comparison of linear array endoscopic ultrasound and helical computed tomography for the staging of periampullary malignancies. Ann Surg Oncol. 10:2003;890-897
21. Clarke D.L., Thompson S.R., Madiba T.E., et al. Preoperative imaging of pancreatic cancer A management-oriented approach. J Am Coll Surg. 196:2003;119-129
22. Stojadinovic A., Brooks A., Hoos A., et al. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg. 196:2003;954-964
23. Chu Q.D., Khushalani N., Javle M.M., et al. Should adjuvant therapy remain the standard of care for patients with resected adenocarcinoma of the pancreas? Ann Surg Oncol. 10:2003;539-545
24. Picozzi V.J., Kozarek R.A., Traverso L.W., et al. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg. 185:2003;476-480
25. Räsänen J.V., Sihvo E.I.T., Knuuti M.J., et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol. 10:2003;954-960
26. van Westreenen H.L., Heeren A.M., Jager P.L., et al. Pitfalls of positive findings in staging esophageal cancer with F-18-flourodeoxyglucose positron emission tomography. Ann Surg Oncology. 10:2003;1100-1105
27. Kaklamanos I.G., Walker G.R., Ferry K., et al. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction a meta-analysis of randomized clinical trials. Ann Surg Oncol. 10:2003;754-761
28. Urschel J.D., Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 185:2003;538-543
29. D'Ugo D.M., Pende V., Persiani R., et al. Laparoscopic staging of gastric cancer an overview. J Am Coll Surg. 196:2003;965-974
30. Fujiwara M., Kodera Y., Kasai Y., et al. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma a review of 43 cases. J Am Coll Surg. 196:2003;75-81
31. Liu K.J.M., Loewen M., Atten M.J., et al. The survival of stage III gastric cancer patients is affected by the number of lymph nodes removed. Surgery. 134:2003;639-646
32. Morgagni P., Saragoni L., Scarpi E., et al. Lymph node micrometastases in early gastric cancer and their impact on prognosis. World J Surg. 27:2003;558-561
33. Nitti D., Marchet A., Olivieri M., et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer analysis of a large European monoinstitutional experience. Ann Surg Oncol. 10:2003;1077-1085
34. Hayashi H., Ochiai T., Mori M., et al. Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. J Am Coll Surg. 196:2003;68-74
35. Pickhardt P.J., Choi R., Hwang I., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 349:2003;2191-2200
36. Allegra C.J., Paik S., Colangelo L.H., et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with duke's B and C colon cancer A National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol. 21:2003;241-250
37. Diep C.B., Thorstensen L., Meling G.I., et al. Genetic tumor markers with prognostic impact in Duke's stages B and C colorectal cancer patients. J Clin Oncol. 21:2003;820-829
38. Bilchik A.J., Nora D.T., Sobin L.H., et al. Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol. 21:2003;668-672
39. Le Voyer T.E., Sigurdson E.R., Hanlon A.J., et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed A secondary survey of intergroup trial INT-0089. J Clin Oncol. 21:2003;2912-2919
40. Joseph N.E., Sigurdson E.R., Hanlon A.L., et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol. 10:2003;213-218
41. Ayanian J.Z., Zaslavsky A.M., Fuchs C.S., et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 21:2003;1293-1300
42. Desai D.C., Zervos E.E., Arnold M.W., et al. Positron emission tomography affects surgical management in recurrent colorectal cancer patients. Ann Surg Oncol. 10:2003;59-64
43. Moore H.G., Akhurst T., Larson S.M., et al. A case-controlled study of 18-fluorodeoxglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg. 197:2003;22-28
44. Holzer B., Urban M., Hölbling N., et al. Magnetic resonance imaging predicts sphincter invasion of low rectal cancer and influences selection of operation. Surgery. 133:2003;656-661
45. Nakagoe T., Yamaguchi E., Tanaka K., et al. Distal intramural spread is an independent prognostic factor for distant metastasis and poor outcome in patients with rectal cancer a multivariate analysis. Ann Surg Oncol. 10:2003;163-170
46. Neary P., Makin G.B., White T.J., et al. Transanal endoscopic microsurgery A viable operative alternative in selected patients with rectal lesions. Ann Surg Oncol. 10:2003;1106-1111
47. Pilati P., Mocellin S., Riccardo C.R., et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol. 10:2003;508-513
48. Glehen O., Mithieux F., Beaujard D.O., et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis a phase II study. J Clin Oncol. 21:2003;799-806
49. McQuellon R.P., Loggie B.W., Lehman A.B., et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol. 10:2003;155-162
50. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 21:2003;3737-3743
51. Glehen O., Osinsky D., Cotte E., et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 10:2003;863-869
52. Bullard K.M., Tuttle T.M., Rothenberger D.A., et al. Surgical therapy for anorectal melanoma. J Am Coll Surg. 196:2003;206-211
53. Pockaj B.A., Jaroszewski D.E., DiCaudo D.J., et al. Changing surgical therapy for melanoma of the external ear. Ann Surg Oncol. 10:2003;689-696
54. Haigh P.I., DiFronzo I.A., McCready D.R., et al. Optimal excision margins for primary cutaneous melanoma A systematic review and meta-analysis. Can J Surg. 46:2003;419-426
55. de Wilt J.H.W., McCarthy W.H., Thompson J.F. Surgical treatment of splenic metastases in patients with melanoma. J Am Coll Surg. 197:2003;38-43
56. Rousseau D.L., Ross M.I., Johnson M.M., et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol. 10:2003;569-574
57. Estourgie S.H., Nieweg O.E., Valdés Olmos R.A., et al. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow up of 6 years. Ann Surg Oncol. 10:2003;681-688
58. Wrightson W.R., Wong S.L., Edwards M.J., et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 10:2003;676-680
59. Carlson G.W., Murray D.R., Lyles R.H., et al. The amount of metastatic melanoma in a sentinel lymph node Does it have prognostic significance? Ann Surg Oncol. 10:2003;575-581
60. Goydos J.S., Patel K.N., Shih W.J., et al. Patterns of recurrence in patients with melanoma and histologically negative but RT-PCR-positive sentinel lymph nodes. J Am Coll Surg. 196:2003;196-205
61. Evans H.L., Krag D.N., Teates C.D., et al. Lymphoscintigraphy and sentinel node biopsy accurately stage melanoma in patients presenting after wide local excision. Ann Surg Oncol. 10:2003;416-425
62. Leong S.P.L., Thelmo M.C., Kim R.P., et al. Delayed harvesting of sentinel lymph nodes after previous wide local excision of extremity melanoma. Ann Surg Oncol. 10:2003;196-200
63. Chao C., Wong S.L., Edwards M.J., et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol. 10:2003;21-26
64. Sabel M.S., Sondak V.K. Pros and cons of adjuvant interferon in the treatment of melanoma. Oncologist. 8:2003;451-458
65. Hwu W., Krown S.E., Menell J.H., et al. Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma. J Clin Oncol. 21:2003;3351-3356
66. Weitz J., Antonescu C.R., Brennan M.F. Localized extremity soft tissue sarcoma improved knowledge with unchanged survival over time. J Clin Oncol. 21:2003;2719-2725
67. Wilkins R.M., Cullen J.W., Odom L., et al. Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity. Ann Surg Oncol. 10:2003;498-507
68. van Etten B., van Geel A.N., de Wilt J.H.W., et al. Fifty tumor necrosis factor-based isolated limb profusions for limb salvage in patients older than 75 years with limb-threatening soft tissue sarcomas and other extremity tumors. Ann Surg Oncol. 10:2003;32-37
69. Gronchi A., Casali P.G., Mariani L., et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis A series of patients surgically treated at a single institution. J Clin Oncol. 21:2003;1390-1397
70. Jakub J.W., Pendas S., Reintgen D.S. Current status of sentinel lymph node mapping and biopsy facts and controversies. Oncologist. 8:2003;59-68
71. Estourgie S.H., Tanis P.J., Nieweg O.E., et al. Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol. 10:2003;935-941
72. Sandias E.E., de Bree E., Tsiftsis D.D., et al. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg. 185:2003;202-210
73. Chua B., Olivotto I.A., Donald J.C., et al. Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996-2001. Am J Surg. 185:2003;118-126
74. Porter G.A., McMulkin H., Lovrics P.J. Sentinel lymph node biopsy in breast cancer Canadian practice patterns. Ann Surg Oncol. 10:2003;255-260
75. D'Eredita G., Ferrarese F., Cecere V., et al. Subareolar injection may be more accurate than other techniques for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 10:2003;942-947
76. Vargas H.I., Vargas M.P., Venegas R., et al. Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer. Am Surg. 69:2003;886-890
77. Hwang R.F., Krishnamurthy S., Hunt K.K., et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 10:2003;248-254
78. Van Zee K.J., Manasseh D.E., Bevilacqua J.L.B., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 10:2003;1140-1151
79. Nos C., Fréneaux P., Louis-Sylvester C., et al. Macroscopic quality control improves the reliability of blue dye-only sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 10:2003;525-530
80. Intra M., Zurrida S., Maffini F., et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol. 10:2003;1160-1165
81. Brady B., Fant J., Jones R., et al. Sentinel lymph node biopsy followed by delayed mastectomy and reconstruction. Am J Surg. 185:2003;114-117
82. Balch G.C., Mithani S.K., Richards K.R., et al. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol. 10:2003;616-621
83. Sabel M.S., Schott A.F., Kleer C.G., et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg. 186:2003;102-105
84. Layeeque R., Henry-Tillman R., Korourian S., et al. Subareolar sentinel node biopsy for multiple breast cancers. Am J Surg. 186:2003;730-736
85. Tousimis E., Van Zee K.J., Fey J.V., et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancer. J Am Coll Surg. 197:2003;529-535
86. Menes T.S., Tartter P.I., Mizrachi H., et al. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol. 10:2003;1166-1170
87. Bochner M.A., Farshid G., Dodd T.J., et al. Intraoperative imprint cytologic assessment of the sentinel node for early breast cancer. World J Surg. 27:2003;430-432
88. Cserni G. Effect of increasing the surface sampled by imprint cytology on the intraoperative assessment of axillary sentinel lymph nodes in breast cancer patients. Am Surg. 69:2003;419-423
89. Karamlou T., Johnson N.M., Chan B., et al. Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer. Am J Surg. 185:2003;425-428
90. Mullenix P.S., Carter P.L., Martin M.J., et al. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer. Am J Surg. 185:2003;420-424
91. Roberts C.A., Beitsch P.D., Litz C.E., et al. Interpretive disparity among pathologists in breast sentinel lymph node evaluation. Am J Surg. 186:2003;324-329
92. Sakaguchi M., Virmani A., Dudak M.W., et al. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. Ann Surg Oncol. 10:2003;117-125
93. Fant J.S., Grant M.D., Knox S.M., et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol. 10:2003;126-130
94. Badgwell B.D., Povoski S.P., Abdessalam S.F., et al. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol. 10:2003;376-380
95. Wright F.C., Walker J., Law C.H.L., et al. Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol. 10:2003;1054-1058
96. Krag D.N., Single R.M. Breast cancer survival according to number of nodes removed. Ann Surg Oncol. 10:2003;1152-1159
97. Beyer T., Moonka R. Normal mammography and ultrasonography in the setting of palpable breast cancer. Am J Surg. 185:2003;416-419
98. Kaufman C.S., Jacobson L., Bachman B., et al. Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients. Am J Surg. 186:2003;378-382
99. Bedrosian I., Bedi D., Kuerer H.M., et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol. 10:2003;1025-1030
100. Quan M.L., Sclafani L., Heerdt A.S., et al. Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncol. 10:2003;1048-1053
101. Furman B., Gardner M.S., Romilly P., et al. Effect of 0.5 Tesla magnetic resonance imaging on the surgical management of breast cancer patients. Am J Surg. 186:2003;344-347
102. Hwang E.S., Kinkel K., Esserman L.J., et al. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ Value in the diagnosis of residual disease, occult invasion and multicentricity. Ann Surg Oncol. 10:2003;381-388
103. Barranger E., Grahak D., Antoine M., et al. Evaluation of flourodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer. Ann Surg Oncol. 10:2003;622-627
104. Skinner K.A., Helspe J.T., Deapen D., et al. Breast cancer Do specialists make a difference? Ann Surg Oncol. 10:2003;606-615
105. Pandelidis S., Heilman D., Jones D., et al. Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions. Ann Surg Oncol. 10:2003;43-47
106. Crowe J.P., Patrick R.J., Rybicki L.A., et al. Does ultrasound core breast biopsy predict histologic finding on excisional biopsy? Am J Surg. 186:2003;397-399
107. Kass R., Henry-Tillman R.S., Nurko J., et al. Touch preparation of breast core needle specimens in a new method for same-day diagnosis. Am J Surg. 186:2003;737-742
108. Cox C.E., Furman B., Stowell N., et al. Radioactive seed localization breast biopsy and lumpectomy can specimen radiographs be eliminated? Ann Surg Oncol. 10:2003;1039-1047
109. Gittleman M.A. Single-step ultrasound localization of breast lesions and lumpectomy procedure. Am J Surg. 186:2003;386-390
110. Tran C., Langer S., Broderick-Villa G., et al. Does reoperation predispose to postoperative wound infection in women undergoing operation for breast cancer? American Surgeon. 69:2003;852-856
111. Tafra L., Smith S.J., Woodward J.F., et al. Pilot trial of cryoprobe-assisted breast-conserving surgery for small ultrasound-visible cancers. Ann Surg Oncol. 10:2003;1018-1024
112. Singletary S.E., Walsh G., Vauthey J., et al. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist. 8:2003;241-251
113. Bouchardy C., Rapiti E., Fioretta G., et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 21:2003;3580-3587
114. Tchen N., Juffs H.G., Downie F.P., et al. Cognitive function, failure and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol. 21:2003;4175-4183
115. Ganz P.A., Greendale G.A., Petersen L., et al. Breast cancer in younger women reproductive and late health effects of treatment. J Clin Oncol. 21:2003;4184-4193
116. Wiedswang G., Borgen E., Kårsen G., et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol. 21:2003;3469-3478
117. Kaufmann M., von Minckwitz G., Smith R., et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer review and recommendations. J Clin Oncol. 21:2003;2600-2608
118. Ring A., Webb A., Ashley S., et al. Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer? J Clin Oncol. 21:2003;4540-4545
119. Wallgren A., Bonetti M., Gelber R.D., et al. Risk factors for locoregional recurrence among breast cancer patients results from international breast cancer study group trials I through VII. J Clin Oncol. 21:2003;1205-1213
120. Chagpar A., Meric-Bernstam F., Hunt K.K., et al. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol. 10:2003;628-634
121. Ho C.M., Mak C.K.L., Lau Y., et al. Skin involvement in invasive breast carcinoma safety of skin-sparing mastectomy. Ann Surg Oncol. 10:2003;102-107
122. Hoogerbrugge N., Bult P., de Widt-Levert L.M., et al. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Oncol. 21:2003;41-45
123. Kriege M., Brekelmans C.T.M., Boctes C. MRI screening for breast cancer in women with high familial and genetic risk first results of the Dutch MRI screen study. ASCO Proc. 2003;. abstract 5, page 2
124. Kuhl C.K., Schrading S., Leutner C.C. Surveillance of "high risk" women with proven or suspected familial (hereditary) breast cancer first mid-term results of a multi-modality clinical screening trial. ASCO Proc. 2003;. abstract 4, page 2
125. Bremer M., Doerk T., Sohn C., et al. Local relapse after postoperative radiotherapy in patients with bilateral breast cancer by BRCA1 or 2 status. ASCO Proc. 2003;. abstract 42, page 11
126. Mincey B.A. Genetics and the management of women at high risk for breast cancer. Oncologist. 8:2003;466-473
127. Zannis V.J., Walker L.C., Barclay-White B., et al. Postoperative ultrasound-guided percutaneous placement of a new breast brachytherapy balloon catheter. Am J Surg. 186:2003;383-385